Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             67 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A dose ranging study designed to assess the safety and efficacy of a low molecular weight heparin fragment (fragmin) as prophylaxis against deep vein thrombosis Kakkar, V.V.
 1987
 45 S1 p. 18-
1 p.
 artikel
2 A double-blind placebo controlled trial to study the efficacy and safety of a low molecular weight heparin fragment (fragmin) in patients having major elective general surgery Ockelford, P.A.
 1987
 45 S1 p. 19-
1 p.
 artikel
3 An investigation of methods to prevent fibrinogen depletion using processing of samples obtained after thrombolytic therapy Greenwood, H.
 1987
 45 S1 p. 74-
1 p.
 artikel
4 A randomized, double blind study of a low molecular weight heparin (KABI 2165) once daily and low dose standard heparin twice daily, in the prevention of postoperative deep vein thrombosis in general surgery 1987
 45 S1 p. 21-
1 p.
 artikel
5 Arteries, veins and endothelium-dependant relaxation: Cellular effects 1987
 45 S1 p. 4-
1 p.
 artikel
6 Author index 1987
 45 S1 p. 83-84
2 p.
 artikel
7 Biochemical properties of human factor VIII:C (monoclate) purified using monoclonal antibody to VWF Berntorp, E.
 1987
 45 S1 p. 60-
1 p.
 artikel
8 Blood products and immune changes: Impacts without HIV infection Aledort, L.M.
 1987
 45 S1 p. 57-
1 p.
 artikel
9 Characterization of hirudins isolated from hirudo medicinalis 1987
 45 S1 p. 32-
1 p.
 artikel
10 Clinical experience with cold sterilized factor IX complex Heinrich, D.
 1987
 45 S1 p. 50-
1 p.
 artikel
11 Clinical experience with sterilized factor VIII concentrates Colombo, M
 1987
 45 S1 p. 48-
1 p.
 artikel
12 Comparison of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction Bonnier, J.J.R.M.
 1987
 45 S1 p. 67-
1 p.
 artikel
13 Comparison of intravenous APSAC (anisoylated plasminogen streptokinase activator complex) and intracoronary streptokinase in acute myocardial infarction: Interim results of the United States randomized study Anderson, J.L.
 1987
 45 S1 p. 68-
1 p.
 artikel
14 Consequences of antibody binding in vitro on the pharmacological properties of APSAC Fears, R.
 1987
 45 S1 p. 77-
1 p.
 artikel
15 Coronary artery patency using eminase (APSAC) in acute myocardial infarction Hillis, W.S.
 1987
 45 S1 p. 69-
1 p.
 artikel
16 Desulfatohirudin, a specific thrombin inhibitor: expression and secretion in yeast 1987
 45 S1 p. 33-
1 p.
 artikel
17 Effect of alloantigens in blood products on immunity Ludlam, C.A.
 1987
 45 S1 p. 55-
1 p.
 artikel
18 Elimination of fragmin under normal and pathological conditions. A preclinical study in rabbits Mattsson, C.
 1987
 45 S1 p. 16-
1 p.
 artikel
19 Epitope mapping and quantitation of hirudin with polyclonal and monoclonal antibodies 1987
 45 S1 p. 38-
1 p.
 artikel
20 Evidence for a sustained fibrinolytic response to APSAC in vitro Fears, R.
 1987
 45 S1 p. 76-
1 p.
 artikel
21 Evidence for multiple binding sites of hirudin in thrombin Villanueva, German B.
 1987
 45 S1 p. 35-
1 p.
 artikel
22 Evidence for the progressive uptake of APSAC by human clots in vitro Fears, R.
 1987
 45 S1 p. 80-
1 p.
 artikel
23 Evidence supporting the proposal that endothelium-derived relaxing factor is nitric oxide 1987
 45 S1 p. 5-
1 p.
 artikel
24 Experimental atherosclerosis reduces both the release and the vascular action of the EDRF 1987
 45 S1 p. 10-
1 p.
 artikel
25 Experimental studies on antithrombotic effects of the naturally occurring thrombin inhibitor hirudin Kaiser, B.
 1987
 45 S1 p. 41-
1 p.
 artikel
26 Fibrinoloytic parameters in patients with acute myocardial infarction treated with intravenous APSAC or intracoronary streptokinase Marder, V.J.
 1987
 45 S1 p. 72-
1 p.
 artikel
27 Fragmin pharmacokinetics in human volunteers Albada, J.
 1987
 45 S1 p. 17-
1 p.
 artikel
28 Hepatitis and factor VIII concentrates Kernoff, P.B.A.
 1987
 45 S1 p. 56-
1 p.
 artikel
29 Hirudins: Structure-function relationships — behavior and effects in in vivo-models Fritz, H.
 1987
 45 S1 p. 40-
1 p.
 artikel
30 Identification by HPLC analysis of the unaltered forms of hirudin and desulfated hirudin after kidney passage Henschen, A.
 1987
 45 S1 p. 37-
1 p.
 artikel
31 Impaired endothelium-dependent relaxation and cyclic guanosine 5′-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta Henry, P.D.
 1987
 45 S1 p. 6-
1 p.
 artikel
32 Initial human studies with factor VIII:C purified from plasma by the use of monoclonal antibodies Levine, P.H.
 1987
 45 S1 p. 61-
1 p.
 artikel
33 Intravenous APSAC versus conventional therapy in patients with acute myocardial infarction. A European Multicentre Study (EMS) Bossaert, L.
 1987
 45 S1 p. 71-
1 p.
 artikel
34 Isolation and characterization of recombinant desulfatohirudin from yeast, a highly selective thrombin inhibitor Grossenbacher, H.
 1987
 45 S1 p. 34-
1 p.
 artikel
35 Isolation and sequence analysis of new hirudin Dominique, Tripier
 1987
 45 S1 p. 31-
1 p.
 artikel
36 Low molecular weight heparin vs. standard heparin in haemodialysis/haemofiltration patients: Results of a multicentre long-term study Schrader, J.
 1987
 45 S1 p. 25-
1 p.
 artikel
37 Modern methods for the preparation of factor VIII using monoclonal antibodies Meyer, D.
 1987
 45 S1 p. 52-
1 p.
 artikel
38 Neutralization of fragmin by protamine after cardio-pulmonary by pass (CPB) using a pig model Bagge, L.
 1987
 45 S1 p. 14-
1 p.
 artikel
39 Overall clinical experience with eminase Johnson, E.S.
 1987
 45 S1 p. 73-
1 p.
 artikel
40 Overview of thrombolytic therapy in acute myocardial infarction Sherry, Sol
 1987
 45 S1 p. 65-
1 p.
 artikel
41 Pharmacokinetic properties of APSAC and other thrombolytic agents in animals and in man Nunn, B.
 1987
 45 S1 p. 78-
1 p.
 artikel
42 Pharmacokinetic studies with hirudin Nowak, G.
 1987
 45 S1 p. 36-
1 p.
 artikel
43 Pharmacological comparison of lys77-plasminogen and glu1-plasminogen forms of APSAC Fears, R
 1987
 45 S1 p. 75-
1 p.
 artikel
44 Platelets, unsaturated fatty acid and endothelium-derived relaxing factor(s) 1987
 45 S1 p. 9-
1 p.
 artikel
45 Preclinical characterization of monoclate Schreiber, A.B.
 1987
 45 S1 p. 59-
1 p.
 artikel
46 Preclinical, pharmacological evaluation of APSAC Ferres, H.
 1987
 45 S1 p. 66-
1 p.
 artikel
47 Preliminary clinical reports on the antithrombotic action of hirudin Vogel, G.
 1987
 45 S1 p. 42-
1 p.
 artikel
48 Prevention of deep vein thrombosis in orthopedic surgery: Fragmin versus Heparin-DHE Breyer, H.-G.
 1987
 45 S1 p. 23-
1 p.
 artikel
49 Properties of fragmin Holmer, E.
 1987
 45 S1 p. 13-
1 p.
 artikel
50 Purification of factor VIII by monoclonal antibody affinity chromatography Zimmerman, T.S.
 1987
 45 S1 p. 58-
1 p.
 artikel
51 Randomised multicentre trial of APSAC versus heparin. Interim results Meinertz, Th.
 1987
 45 S1 p. 70-
1 p.
 artikel
52 Release of nitric oxide accounts for the anti-platelet activity of endothelium derived relaxing factor (EDRF): Interactions with Prostacyclin 1987
 45 S1 p. 8-
1 p.
 artikel
53 Safety of 3-propiolactone (β-PL)/UV treated PPSB (factor IX concentrate) 1987
 45 S1 p. 49-
1 p.
 artikel
54 Sc. Kabi 2165 in the treatment of deep venous thrombosis (DVT) of the leg Bratt, G.
 1987
 45 S1 p. 24-
1 p.
 artikel
55 Stimulation of soluble guanylate cyclase activity by endothelium-derived relaxant factor: A general principle of its vasodilator and antiaggregatory properties 1987
 45 S1 p. 3-
1 p.
 artikel
56 Swedish - Norwegian multicenter trial: A randomized double blind study on the prevention of postoperative deep vein thrombosis (DVT) - heparin fragment (fragmin) from the evening before surgery vs conventional low-dose heparin Berqqvist, D
 1987
 45 S1 p. 20-
1 p.
 artikel
57 The clinical potential of hirudin 1987
 45 S1 p. 43-
1 p.
 artikel
58 The comeback of hirudin — an old-established anticoagulant agent Markwardt, F.
 1987
 45 S1 p. 29-
1 p.
 artikel
59 The effect of heparin and fibrin on the enzymatic efficiencies of thrombolytics in vitro Fears, R.
 1987
 45 S1 p. 79-
1 p.
 artikel
60 The production and evaluation of recombinant hirudin Courtney, M.
 1987
 45 S1 p. 30-
1 p.
 artikel
61 The protective effect of acylation on the stability of APSAC in human plasma Fears, R.
 1987
 45 S1 p. 81-
1 p.
 artikel
62 The relationship between inhibitory factor, EDRF, nitrite and nitric oxide Martin, W.
 1987
 45 S1 p. 7-
1 p.
 artikel
63 The role of chimpanzees in the quest for virus-free blood derivatives Prince, Alfred M.
 1987
 45 S1 p. 47-
1 p.
 artikel
64 Thrombosis prophylaxis with low molecular weight heparin in total hip replacement, fragmin versus dextran Eriksson, B.
 1987
 45 S1 p. 22-
1 p.
 artikel
65 Toxicological studies with recombinant hirudin Klöcking, H.-P.
 1987
 45 S1 p. 39-
1 p.
 artikel
66 Vascular cell reactions with heparins Tobelem, G.
 1987
 45 S1 p. 15-
1 p.
 artikel
67 Virus sterilization of plasma proteins by treatment with solvent/detergent mixtures — a summary Horowitz, B.
 1987
 45 S1 p. 51-
1 p.
 artikel
                             67 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland